Vasomune Therapeutics Inc.
$2,849,345.00 CAD
≈ 37 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- November 1, 2020 – February 28, 2023
- Reference
- nrc-cnrc:172-2020-2021-Q4-965762
Published purpose
Vasomune is developing a novel first-in-class investigational medicine to treat patients hospitalized with severe COVID-19 disease. The phase 1 study is the first-in-human study designed to demonstrated safety and tolerability of AV-001 in heathy subjects prior to testing in severely ill patients with COVID-19 disease.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions